External Oblique Intercostal Plane Block for Liver Transplantation Donors
1 other identifier
interventional
64
1 country
1
Brief Summary
Postoperative pain management is one of the important factors to improve rehabilitation and enhance recovery. External oblique intercostal plane block may be used for abdominal wall analgesia to provide effective analgesia for abdominal surgery. The aim of this study is to investigate the postoperative analgesic efficacy of external oblique intercostal plane block and subcostal transversus abdominis plane block in living liver donors. Researchers will compare the external oblique intercostal plane block group with subcostal transversus abdominis plane block to see if the external oblique intercostal plane block is effective for postoperative analgesia in living liver donors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2023
CompletedFirst Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
June 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2024
CompletedMarch 19, 2024
May 1, 2023
7 months
May 25, 2023
March 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Morphine consumption
The amount of morphine required by the patient and given by the device will be recorded for the first 24 hours.
Postoperative 24 hours
Secondary Outcomes (3)
Postoperative visual analog scale scores
Postoperative 24 hours
Rescue analgesic drug consumption
postoperative 24 hours
Incidence of postoperative nausea and vomiting
postoperative 24 hours
Study Arms (2)
Subcostal transversus abdominis plane block group
ACTIVE COMPARATORThe patients in subcostal transversus abdominis plane block group will be received subcostal transversus abdominis plane block and patient controlled analgesia with morphine for postoperative analgesia
External oblique intercostal plane block group
ACTIVE COMPARATORThe patients in External oblique intercostal plane block group will be received external oblique intercostal plane block and patient controlled analgesia with morphine for postoperative analgesia
Interventions
External oblique intercostal plane block will be administered at the end of the surgery and after skin closure.
External oblique intercostal plane block will be administered at the end of the surgery and after skin closure. .
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years
- Patients with American Society of Anesthesiology (ASA) physical status I-II
- Patients scheduled for a living donor hepatectomy
You may not qualify if:
- Allergy to local anesthetics
- Coagulopathy
- Skin infection at the block area
- Advanced renal failure
- Chronic pain syndromes
- Alcohol or drug abuse
- Psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istinye University Hospital
Istanbul, Turkey (Türkiye)
Related Publications (1)
Sahin T, Kavakli AS, Eren E, Aydin A, Sahin NK, Tokac M, Dinckan A. Ultrasound-guided external oblique intercostal plane block versus subcostal transversus abdominis plane block for postoperative analgesia in living liver donors: A prospective randomized trial. J Clin Anesth. 2025 Sep;106:111971. doi: 10.1016/j.jclinane.2025.111971. Epub 2025 Aug 19.
PMID: 40840080DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taylan Sahin, M.D.
Istinye University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2023
First Posted
June 6, 2023
Study Start
May 8, 2023
Primary Completion
December 14, 2023
Study Completion
January 17, 2024
Last Updated
March 19, 2024
Record last verified: 2023-05